Dr. Benz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4460 Bissonnet
Ste 200
Bellaire, TX 77401Phone+1 713-524-3434
Summary
- Dr. Matthew Benz is an ophthalmologist in Houston, TX and is affiliated with Retina Consultants of Texas. He received his medical degree from University of Michigan Medical School and has been in practice 20 years. He specializes in retinal disease and is experienced in vitreoretinal disease.
Education & Training
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1998 - 2001
Advocate Illinois Masonic Medical CenterInternship, Transitional Year, 1997 - 1998
University of Michigan Medical SchoolClass of 1997
Certifications & Licensure
TX State Medical License 2003 - 2024
FL State Medical License 2001 - 2006- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Start of enrollment: 2012 Oct 01
- Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. Start of enrollment: 2014 Sep 23
Publications & Presentations
PubMed
- 10 citationsRetinal detachment in patients with a preexisting glaucoma drainage device: anatomic, visual acuity, and intraocular pressure outcomes.Matthew S. Benz, Ingrid U. Scott, Harry W. Flynn, Steven J. Gedde
Retina. 2002-06-01 - 59 citationsComplications of systemic chemotherapy as treatment of retinoblastoma.Matthew S Benz, Ingrid U. Scott, Timothy G. Murray, Deborah Kramer, Stuart Toledano
Archives of Ophthalmology. 2000-04-01 - 57 citationsMacular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.Nizar Saleh Abdelfattah, Mayss Al-Sheikh, Sean Pitetta, Ahmed Mousa, Srinivas R. Sadda
Ophthalmology. 2017-02-01
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
